These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 21148399)
21. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457 [TBL] [Abstract][Full Text] [Related]
22. Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Clemons NJ; McColl KE; Fitzgerald RC Gastroenterology; 2007 Oct; 133(4):1198-209. PubMed ID: 17919494 [TBL] [Abstract][Full Text] [Related]
23. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796 [TBL] [Abstract][Full Text] [Related]
24. Role of interleukin-6 in Barrett's esophagus pathogenesis. Dvorak K; Dvorak B World J Gastroenterol; 2013 Apr; 19(15):2307-12. PubMed ID: 23613623 [TBL] [Abstract][Full Text] [Related]
25. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236 [TBL] [Abstract][Full Text] [Related]
26. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542 [TBL] [Abstract][Full Text] [Related]
27. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Isomoto H; Kobayashi S; Werneburg NW; Bronk SF; Guicciardi ME; Frank DA; Gores GJ Hepatology; 2005 Dec; 42(6):1329-38. PubMed ID: 16317687 [TBL] [Abstract][Full Text] [Related]
29. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Konturek PC; Burnat G; Rau T; Hahn EG; Konturek S Dig Dis Sci; 2008 Mar; 53(3):597-605. PubMed ID: 17763959 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells. Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278 [TBL] [Abstract][Full Text] [Related]
31. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1. Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802 [TBL] [Abstract][Full Text] [Related]
32. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma. Keles M; Sahin I; Kurt A; Bozoglu C; Simsek G; Kabalar E; Tatar A Afr Health Sci; 2019 Mar; 19(1):1671-1676. PubMed ID: 31148997 [TBL] [Abstract][Full Text] [Related]
35. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus. Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220 [TBL] [Abstract][Full Text] [Related]
36. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas. Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451 [TBL] [Abstract][Full Text] [Related]
37. Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment. Hritz I; Gyorffy H; Molnar B; Lakatos G; Sipos F; Pregun I; Juhasz M; Pronai L; Schaff Z; Tulassay Z; Herszenyi L Pathol Oncol Res; 2009 Jun; 15(2):183-92. PubMed ID: 18752044 [TBL] [Abstract][Full Text] [Related]
38. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431 [TBL] [Abstract][Full Text] [Related]
39. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z. Wu MH; Chen XY; Cai KR Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma. Guo Y; Bao Y; Ma M; Zhang S; Zhang Y; Yuan M; Liu B; Yang Y; Cui W; Ansong E; Dong H; Macias V; Yang W Oncotarget; 2017 May; 8(20):33285-33299. PubMed ID: 28402280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]